Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Depreciation & Amortization (IS) (2019 - 2024)

Selectis Health's Depreciation & Amortization (IS) history spans 7 years, with the latest figure at $362723.0 for Q4 2024.

  • For Q4 2024, Depreciation & Amortization (IS) fell 15.79% year-over-year to $362723.0; the TTM value through Dec 2024 reached $1.6 million, down 5.78%, while the annual FY2024 figure was $1.6 million, 5.78% down from the prior year.
  • Depreciation & Amortization (IS) for Q4 2024 was $362723.0 at Selectis Health, down from $374118.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $453608.0 in Q3 2022 and bottomed at $357868.0 in Q3 2023.
  • The 5-year median for Depreciation & Amortization (IS) is $427176.5 (2023), against an average of $417133.0.
  • The largest annual shift saw Depreciation & Amortization (IS) grew 25.56% in 2020 before it fell 21.11% in 2023.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $405401.0 in 2020, then rose by 10.28% to $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then dropped by 15.79% to $362723.0 in 2024.
  • Per Business Quant, the three most recent readings for GBCS's Depreciation & Amortization (IS) are $362723.0 (Q4 2024), $374118.0 (Q3 2024), and $409530.0 (Q2 2024).